Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 2,189 CADL shares, $19.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 2,189 | $19.0K |
| Jul 1, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 2,199 | $19.0K |
| Jun 24, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 32,000 | n/a |
| Jun 18, 2026 | Liquidia Corp (LQDA) | Grant/Award | 5,882 | n/a |
| Jun 8, 2026 | Liquidia Corp (LQDA) | Sale | 11,513 | $726.8K |
| Apr 2, 2026 | Candel Therapeutics, Inc. (CADL) | Grant/Award | 4,618 | $19.0K |
| Feb 27, 2026 | Candel Therapeutics, Inc. (CADL) | Purchase | 550,458 | $3.00M |
| Feb 13, 2026 | Liquidia Corp (LQDA) | Other (see footnotes) | 55,116 | $2.35M |
| Nov 26, 2025 | Verrica Pharmaceuticals Inc. (VRCA) | Purchase | 1,375,380 | $5.84M |
| Sep 2, 2025 | Liquidia Corp (LQDA) | Sale | 154,337 | $4.31M |